[Immunogenic cardiac amyloidosis. Value of ultrasonography and endomyocardial biopsy].
The development of one dimensional, and more especially two dimensional, cardiac ultrasonography associated with a safe technique of percutaneous endomyocardial biopsy has radically changed the diagnostic approach to cardiac amyloidosis. Prior to the widespread use of these techniques, the ante-mortem diagnosis was only made in 25 p. cent of patients presenting this form of infiltrating cardiomyopathy. The description of a recent case serves as an introduction to a brief review of cardiac amyloidosis based essentially on the two new diagnostic techniques of cardiac ultrasonography and endomyocardial biopsy.
D000686:Amyloidosis / Q000175:diagnosis* / Q000473:pathology / Q000503:physiopathology; D001706:Biopsy; D009202:Cardiomyopathies / Q000175:diagnosis* / Q000473:pathology / Q000503:physiopathology; D004452:Echocardiography; D004562:Electrocardiography; D006439:Hemodynamics; D006801:Humans; D008297:Male; D008875:Middle Aged; D014463:Ultrasonography
Amyloïdose cardiaque immunogénique. Apport de l'échographie et de la biopsie endomyocardique.